These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 18089649)
1. Neurofibromin as a regulator of melanocyte development and differentiation. Diwakar G; Zhang D; Jiang S; Hornyak TJ J Cell Sci; 2008 Jan; 121(Pt 2):167-77. PubMed ID: 18089649 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of neurofibromin gene dosage on melanocyte development. Deo M; Huang JL; Fuchs H; de Angelis MH; Van Raamsdonk CD J Invest Dermatol; 2013 Jan; 133(1):49-58. PubMed ID: 22810304 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene. Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338 [TBL] [Abstract][Full Text] [Related]
4. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Wu X; Estwick SA; Chen S; Yu M; Ming W; Nebesio TD; Li Y; Yuan J; Kapur R; Ingram D; Yoder MC; Yang FC Hum Mol Genet; 2006 Oct; 15(19):2837-45. PubMed ID: 16893911 [TBL] [Abstract][Full Text] [Related]
5. Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed cell migration independent of its function in cell survival. Wehrle-Haller B; Meller M; Weston JA Dev Biol; 2001 Apr; 232(2):471-83. PubMed ID: 11401406 [TBL] [Abstract][Full Text] [Related]
6. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420 [TBL] [Abstract][Full Text] [Related]
7. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530 [TBL] [Abstract][Full Text] [Related]
8. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142 [TBL] [Abstract][Full Text] [Related]
9. NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. Larribere L; Wu H; Novak D; Galach M; Bernhardt M; Orouji E; Weina K; Knappe N; Sachpekidis C; Umansky L; Beckhove P; Umansky V; De Schepper S; Kaufmann D; Ballotti R; Bertolotto C; Utikal J Pigment Cell Melanoma Res; 2015 Jul; 28(4):407-16. PubMed ID: 25824590 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Li F; Munchhof AM; White HA; Mead LE; Krier TR; Fenoglio A; Chen S; Wu X; Cai S; Yang FC; Ingram DA Hum Mol Genet; 2006 Jun; 15(11):1921-30. PubMed ID: 16644864 [TBL] [Abstract][Full Text] [Related]
11. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. Ingram DA; Yang FC; Travers JB; Wenning MJ; Hiatt K; New S; Hood A; Shannon K; Williams DA; Clapp DW J Exp Med; 2000 Jan; 191(1):181-8. PubMed ID: 10620616 [TBL] [Abstract][Full Text] [Related]
12. Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes. Arun V; Worrell L; Wiley JC; Kaplan DR; Guha A FEBS Lett; 2013 May; 587(10):1466-73. PubMed ID: 23583712 [TBL] [Abstract][Full Text] [Related]
14. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Xu J; Ismat FA; Wang T; Yang J; Epstein JA Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772 [TBL] [Abstract][Full Text] [Related]
15. In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells. Allouche J; Bellon N; Saidani M; Stanchina-Chatrousse L; Masson Y; Patwardhan A; Gilles-Marsens F; Delevoye C; Domingues S; Nissan X; Martinat C; Lemaitre G; Peschanski M; Baldeschi C Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9034-9. PubMed ID: 26150484 [TBL] [Abstract][Full Text] [Related]
16. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation. Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122 [TBL] [Abstract][Full Text] [Related]
17. Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients. Kaufmann D; Bartelt B; Hoffmeyer S; Müller R Arch Dermatol Res; 1999 Jun; 291(6):312-7. PubMed ID: 10421056 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Abramowicz A; Gos M Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393 [TBL] [Abstract][Full Text] [Related]